Eastman Chemical Company
NYSE:EMNChemicals
-$1.16 today
- Market cap
- $7.13B
- Beta
- 1.07
- P/E (TTM)
- 20.6
- EPS (TTM)
- $3.50
- Dividend yield
- 4.65%
Volume 1.38M
Average 1.33M
EMN Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Eastman Chemical CompanyNYSE: EMN
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables grows, but more slowly than its trailing trend
Q2 FY2026 accounts receivables of $147M (cash outflow) rose 61.5% year over year, behind the +635.3% change in trailing-twelve-month accounts receivables. Sequentially, it fell 33.8% from the prior quarter. Over 3 fiscal years it compounded at -13.1% a year.
Context
- Accounts receivables amounted to 0.7% of revenue in FY2025, up 0.4 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +61.5% toward the trailing-twelve-month pace of +635.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 61M USD
- Year-over-year change
- +117.9%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 61M | +117.9% |
| FY2024 | 2024-12-31 | 28M | -77.8% |
| FY2023 | 2023-12-31 | 126M | +35.5% |
| FY2022 | 2022-12-31 | 93M | +133.1% |
| FY2021 | 2021-12-31 | (281M) | — |
Accounts Receivables vs competitors
How EMN compares with its peers on the latest reported figures
- EMN's LTM Jun 2026 accounts receivables of $125M is the 3rd largest of the 11 companies compared; the peer median is $15.95M.
- Its year-over-year change of +635.3% is the 2nd highest of 11, against a peer median of -11.5%.
- Accounts receivables amounts to 1.4% of revenue for EMN, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.14B | -688.1% | -60.5% | 2.7% | |
| LTM Sep 2026 | $203M | +2800.0% | -64.1% | 1.8% | |
| LTM Jun 2026 | $125M | +635.3% | -13.1% | 1.4% | |
| LTM Jun 2026 | $91.2M | +328.2% | — | 5.0% | |
| LTM Sep 2026 | $44.7M | +181.1% | — | 1.3% | |
| LTM Sep 2026 | $31.9M | -9.1% | — | 0.9% | |
| LTM Mar 2026 | $25M | -13.8% | -47.1% | 0.4% | |
| LTM Mar 2026 | $17.88M | +8.9% | — | 0.8% | |
| LTM Sep 2026 | $5.1M | -54.9% | — | 0.5% | |
| LTM Jun 2026 | $1M | -98.5% | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding EMN) | $15.95M | -11.5% | -60.5% | 0.8% | |
Competitors are the stored peer set for EMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 867M | 796M | 896M | 908M | 474M |
| Depreciation & Amortization | 538M | 477M | 498M | 509M | 513M |
| Deferred Income Tax | (38M) | (136M) | (102M) | (52M) | 141M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (27M) | 13M | 291M | (29M) | (186M) |
| Accounts Receivables | (281M) | 93M | 126M | 28M | 61M |
| Inventory | (389M) | (430M) | 201M | (344M) | 24M |
| Accounts Payables | 554M | 60M | (190M) | 188M | (76M) |
| Other Working Capital | 89M | 290M | 154M | 99M | (195M) |
| Other Non-Cash Items | 279M | (175M) | (209M) | (49M) | 28M |
| Operating Cash Flow | 1.62B | 975M | 1.37B | 1.29B | 970M |
| Capital Expenditures | (578M) | (611M) | (828M) | (599M) | (546M) |
| Acquisitions (Net) | 553M | 997M | 379M | 38M | 38M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (27M) | 6M | 17M | 27M | 46M |
| Investing Cash Flow | (29M) | 392M | (432M) | (534M) | (462M) |
| Debt Repayment | (350M) | 76M | (338M) | 198M | (304M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1B) | (1B) | (150M) | (300M) | (100M) |
| Dividends Paid | (375M) | (381M) | (376M) | (379M) | (381M) |
| Other Financing Activities | 35M | (14M) | (24M) | 27M | (12M) |
| Financing Cash Flow | (1.69B) | (1.32B) | (888M) | (454M) | (797M) |
| Effect of Forex Changes | (5M) | (12M) | 1M | (10M) | 18M |
| Net Change in Cash | (105M) | 34M | 55M | 289M | (271M) |
| Free Cash Flow | 1.04B | 364M | 546M | 688M | 424M |
Eastman Chemical Company
NYSE:EMN
Intrinsic Alpha fair value
Locked
Current Price
$62.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.